Mutations Status of NOTCH Signaling Pathway Predict Prognosis of Immune Checkpoint Inhibitors in Colorectal Cancer

PURPOSE: In recent years, tumour immunotherapy has ushered in a new era of oncology treatment. However, the use of immune checkpoint inhibitors (ICIs) in the treatment of CRC remains limited. There is an urgent clinical need for precise biomarkers that can aid in the screening and treatment of CRC s...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Anqi, Yao, Jiarong, Cheng, Quan, Liu, Zaoqu, Luo, Peng, Zhang, Jian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10120821/
https://www.ncbi.nlm.nih.gov/pubmed/37092128
http://dx.doi.org/10.2147/JIR.S394894

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10120821/
https://www.ncbi.nlm.nih.gov/pubmed/37092128
http://dx.doi.org/10.2147/JIR.S394894

Ejemplares similares